{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T16:19:30Z","timestamp":1697300370065},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,8,20]],"date-time":"2005-08-20T00:00:00Z","timestamp":1124496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00467-005-2025-3","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T12:00:47Z","timestamp":1124452847000},"page":"1744-1749","source":"Crossref","is-referenced-by-count":32,"title":["High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity"],"prefix":"10.1007","volume":"20","author":[{"given":"Yoshiyuki","family":"Ohtomo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-ichiro","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitohiko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,20]]},"reference":[{"key":"2025_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ki.1978.23","volume":"13","author":"International","year":"1978","unstructured":"International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13:159\u2013165","journal-title":"Kidney Int"},{"key":"2025_CR2","unstructured":"Clark AG, Barratt TM (1999) Steroid-responsive nephrotic syndrome. In: Barratt TM, Avner ED, Harmon WE (eds) Pediatric Nephrology, 4th edn. Lippincott, Baltimore, pp\u00a0731\u2013747"},{"key":"2025_CR3","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1046\/j.1523-1755.2001.0590051919.x","volume":"59","author":"Durkan","year":"2001","unstructured":"Durkan AM, Hodson EM, Willis NS, Craig JC (2001) Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials. Kidney Int 59:1919\u20131927","journal-title":"Kidney Int"},{"key":"2025_CR4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00856511","volume":"8","author":"Hulton","year":"1994","unstructured":"Hulton SA, Dillion MJ, Barratt TM (1994) Long-term cyclosporin therapy in minimal change nephrotic syndrome of childhood. Pediatr Nephrol 8:401\u2013403","journal-title":"Pediatr Nephrol"},{"key":"2025_CR5","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1542\/peds.105.6.1242","volume":"105","author":"Hogg","year":"2002","unstructured":"Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J (2002) Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE). Pediatrics 105:1242\u20131249","journal-title":"Pediatrics"},{"key":"2025_CR6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","volume":"61","author":"Tricontinental","year":"1996","unstructured":"Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group (1996) A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61:1029\u20131037","journal-title":"Transplantation"},{"key":"2025_CR7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00467-003-1175-4","volume":"18","author":"Barletta","year":"2003","unstructured":"Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB (2003) Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol 18:833\u2013837","journal-title":"Pediatr Nephrol"},{"key":"2025_CR8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","volume":"19","author":"Gellermann","year":"2004","unstructured":"Gellermann J, Querfeld U (2004) Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol 19:101\u2013104","journal-title":"Pediatr Nephrol"},{"key":"2025_CR9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/0929867043455648","volume":"11","author":"Pankiewicz","year":"2004","unstructured":"Pankiewicz KW, Patterson SE, Black PL, Jayaram HN, Risal D, Goldstein BM, Stuyver LJ, Schinazi RF (2004) Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH) \u2013 the major therapeutic target. Curr Med Chem 11:887-900","journal-title":"Curr Med Chem"},{"key":"2025_CR10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5414\/CNP60390","volume":"60","author":"Tanaka","year":"2003","unstructured":"Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Waga S (2003) Mizoribine oral therapy for patients with disease flare of lupus nephritis. Clin Nephrol 60:390\u2013394","journal-title":"Clin Nephrol"},{"key":"2025_CR11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","volume":"34","author":"Schwartz","year":"1987","unstructured":"Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571\u2013590","journal-title":"Pediatr Clin North Am"},{"key":"2025_CR12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0006-2952(95)00026-V","volume":"49","author":"Hager","year":"1995","unstructured":"Hager PW, Collart FR, Huberman E, Mitchell BS (1995) Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding. Biochem Pharmacol 49:1323\u20131329","journal-title":"Biochem Pharmacol"},{"key":"2025_CR13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/092986730607220401123549","volume":"6","author":"Ishikawa","year":"1999","unstructured":"Ishikawa H (1999) Mizoribine and mycophenolate mofetil. Curr Med Chem 6:575\u2013597","journal-title":"Curr Med Chem"},{"key":"2025_CR14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00007890-198302000-00007","volume":"35","author":"Kamata","year":"1983","unstructured":"Kamata K, Okubo M, Ishigamori E, Masaki Y, Uchida H, Watanabe K, Kashiwagi N (1983) Immunosuppressive effect of bredinin on cell-mediated and humoral immune reactions in experimental animals. Transplantation 35:144\u2013149","journal-title":"Transplantation"},{"key":"2025_CR15","first-page":"671","volume":"41","author":"Dayton","year":"1992","unstructured":"Dayton JS, Turka LA, Thompson CB, Mitchell BS (1992) Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism. Mol Pharmacol 41:671\u2013676","journal-title":"Mol Pharmacol"},{"key":"2025_CR16","first-page":"940","volume":"87","author":"Turka","year":"1991","unstructured":"Turka LA, Dayton J, Sinclair G, Thompson CB, Mitchell BS (1991) Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine J Clin Invest 87:940\u2013948","journal-title":"Mechanism of action of the immunosuppressive drug mizoribine J Clin Invest"},{"key":"2025_CR17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1328-8067.2001.01531.x","volume":"44","author":"Tsuzuki","year":"2002","unstructured":"Tsuzuki K (2002) Role of mizoribine in renal transplantation. Pediatr Int 44:224\u2013231","journal-title":"Pediatr Int"},{"key":"2025_CR18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s004670050351","volume":"11","author":"Hamasaki","year":"1997","unstructured":"Hamasaki T, Mori M, Kinoshita Y, Saeki T, Sakano T (1997) Mizoribine in steroid-dependent nephrotic syndrome of childhood. Pediatr Nephrol 11:625\u2013627","journal-title":"Pediatr Nephrol"},{"key":"2025_CR19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-1755.2000.00168.x","volume":"58","author":"Yoshioka","year":"2000","unstructured":"Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, Tanizawa T, Wada H, Maki S, for the Pediatric Mizoribine Study Group in Japan (2000) A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int 58:317\u2013324","journal-title":"Kidney Int"},{"key":"2025_CR20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1328-8067.2001.01533.x","volume":"44","author":"Honda","year":"2002","unstructured":"Honda M (2002) Nephrotic syndrome and mizoribine in children. Pediatr Int 44:210\u2013216","journal-title":"Pediatr Int"},{"key":"2025_CR21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.ajkd.2003.08.011","volume":"42","author":"Bagga","year":"2003","unstructured":"Bagga A, Hari P, Moudgil A, Jordan SC (2003) Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 42:1114\u20131120","journal-title":"Am J Kidney Dis"},{"key":"2025_CR22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00467-003-1175-4","volume":"18","author":"Barletta","year":"2003","unstructured":"Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB (2003) Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol 18:833\u2013837","journal-title":"Pediatr Nephrol"},{"key":"2025_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","volume":"19","author":"Gellermann","year":"2004","unstructured":"Gellermann J, Querfeld U (2004) Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol 19:101\u2013104","journal-title":"Pediatr Nephrol"},{"key":"2025_CR24","first-page":"2643","volume":"28","author":"Sonda","year":"1996","unstructured":"Sonda K, Takahashi K, Tanabe K, Funchinoue S, Hayasaka Y, Kawaguchi H, Teraoka S, Toma H, Ota K (1996) Clinical pharmacokinetic study of mizoribine in renal transplantation patients. Transplant Proc 28:2643\u20133648","journal-title":"Transplant Proc"},{"key":"2025_CR25","first-page":"631","volume":"34","author":"Koshikawa","year":"1993","unstructured":"Koshikawa S, Sato M, Narita M, Sakai O, Nakajima M (1993) Clinical evaluation of an immunosuppressive drug, mizoribine (HE-69) on steroid-resistant nephrotic syndrome: a multicenter double-blind comparison study with placebo (in Japanese). Jin To Tohseki 34:631\u2013650","journal-title":"Jin To Tohseki"},{"key":"2025_CR26","first-page":"705","volume":"47","author":"Yumura","year":"1999","unstructured":"Yumura W, Uchida K, Kawashima A, Kobayashi H, Miwa N, Honda K, Nitta K, Nihei H (1999) Evaluation of plasma concentration of mizoribine as an immunosuppressive agent in lupus nephritis patients (in Japanese). Jin To Tohseki 47:705\u2013708","journal-title":"Jin To Tohseki"},{"key":"2025_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/bbrc.2000.3104","volume":"274","author":"Takahashi","year":"2000","unstructured":"Takahashi S, Wakui H, Gustafsson JA, Zilliacus J, Itoh H (2000) Functional interaction of the immunosuppressant mizoribine with the 14\u20133-3 protein. Biochem Biophys Res Commun 274:87\u201392","journal-title":"Biochem Biophys Res Commun"},{"key":"2025_CR28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00467-004-1647-1","volume":"20","author":"Kawasaki","year":"2005","unstructured":"Kawasaki Y, Suzuki J, Takahashi A, Isome M, Nozawa R, Suzuki H (2005) Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome. Pediatr Nephrol 20:96\u201398","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-005-2025-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-005-2025-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-005-2025-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T07:21:44Z","timestamp":1683184904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-005-2025-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,20]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1007\/s00467-005-2025-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,20]]}}}